Ernexa Therapeutics Inc. Class of Warrant or Right, Outstanding
Ernexa Therapeutics Inc. (ERNA) had Class of Warrant or Right, Outstanding of 856.30 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-06
- 2026-06-30: Class of Warrant or Right, Outstanding 856.30K shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 856.61K shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 16.61K shares; Class of Warrant or Right, Outstanding as first filed 415.00K shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 415.00K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 856.30K shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 856.61K shares 10-Q · filed 2026-05-11 | |
| 2025-12-31 | 16.61K shares 10-Q · filed 2026-08-06 | 415.00K shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 415.00K shares 10-Q · filed 2025-11-07 | |
| 2025-06-30 | 763.00K shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 1.61M shares 10-Q · filed 2025-05-07 | |
| 2024-12-31 | 157.00K shares 10-K · filed 2026-03-13 | 2.36M shares 10-K · filed 2025-03-12 |
| 2024-09-30 | 20.39M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 20.39M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 20.39K shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 1.26M shares 10-K · filed 2026-03-13 | 18.92K shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 10.81K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 4.71K shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 4.71K shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 4.71K shares 10-K · filed 2024-03-14 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |